model breast cancer screening model breast cancer screening appropriate screening policy model detection rates incidence interval cancers recent screening projects Utrecht Nijmegen Netherlands model-predicted mortality rate reduction accordance results Kopparberg/Ostergotland trial Sweden Key parameters model duration preclinical stages sensitivity mammography average duration years age increases years age sensitivity high tumors cm model prospective evaluation effects costs various policies 